FDC LTD. - US-FDA Inspection At Company''s Manufacturing Facility Located At Baddi, Himachal Pradesh
Download
|
< Back
|
23 Aug 2024
|
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are pleased to inform you that U.S Food and Drug Administration (FDA) had conducted an inspection at Company''s manufacturing facility located at Baddi, Himachal Pradesh which is dedicated for manufacturing Cephalosporin Oral dosage forms.
The said audit has been successfully completed by the US FDA with "No observation" (Zero 483''s)
|
View all announcements for FDC LTD.
|
Source:
BSE India
|